
|Articles|October 3, 2007
Pediatric Lamisil granules get FDA nod
Lamisil oral granules are approved by the FDA for tinea capitis
Advertisement
Terbinafine (Lamisil, Novartis) oral granules have been approved for the treatment of tinea capitis in children aged four years and older. Novartis developed the new formulation in response to a written request from the FDA for the product. The granules can be sprinkled on food and are approved to be administered once daily for six weeks.
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































